Official Title
Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.
Brief Summary

Since December 2019, a new agent, the coronavirus SARS-Cov-2, has spread from China to the rest of the world causing an international epidemic of respiratory diseases called COVID-19. Oise was one of the first clusters in France, with more than 4,000 confirmed cases. A significant proportion (80%) of patients with COVID-19 are ambulatory. However, few data are available for this particular population in France. Thus, few clear recommendations are available. We propose to conduct a large cohort of observation of suspected or confirmed COVID-19 patients on an ambulatory basis in the Oise region. This observatory will make it possible to describe the epidemiological characteristics and initial management of COVID-19 patients and to identify early severity factors.

Unknown status
COVID-19

Other: observational

observational management of outpatients COVID 19

Eligibility Criteria

Inclusion Criteria:

- patients with covid 19 symptoms

- patients who had a contact with a person PCR Covid 19+

Exclusion Criteria:

- none

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: 99 Years
Countries
France
Locations

Msp de Creil
Creil, France

Investigator: Svetlane DIMI

Contacts

Svetlane DIMI, M.D
+33650002085
svetlane.dimi@sfr.fr

Maison de Sante Pluridisciplinaire de Creil
NCT Number
Keywords
ambulatory
outpatients
COVID 19
Oise, France
MeSH Terms
COVID-19